← Browse by Condition
Medical Condition

prostate cancer patients treated by radiotherapy

Total Trials
1
Recruiting Now
1
Trial Phases
Phase 2
NCT07332000 Phase 2
Recruiting

A Biomarker Study in Men With Localized Prostate Cancer Treated With Aglatimagene Besadenovec

Enrollment
45 pts
Location
United States
Sponsor
Candel Therapeutics, Inc.
View Trial →